SCHEMBL7418534

SCHEMBL7418534

CC(C)C(NC(=O)CNS(=O)(=O)CCc1ccccn1)C(=O)O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ELANE P08246 1/20 0.49
ADAMTS4 O75173 1/20 0.45
MMP8 P22894 2/20 0.43
MMP12 P39900 2/20 0.43
MMP13 P45452 2/20 0.43
MMP1 P03956 1/20 0.43
MMP7 P09237 1/20 0.43
HTT P42858 1/20 0.43
ATM Q13315 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.42
MEN1 O00255 1/20 0.42
ALDH1A1 P00352 1/20 0.42
KMT2A Q03164 1/20 0.42
RAB9A P51151 2/20 0.42
CYP1A2 P05177 1/20 0.42
LMNA P02545 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
MBTPS1 Q14703 1/20 0.41
PKM P14618 1/20 0.41
PTPRA P18433 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7414375 1.00 ELANE (0.49) ELANEADAMTS4MMP8MMP12MMP13
SCHEMBL7332138 0.83 ADAMTS4 (0.55) ELANEADAMTS4MMP13MMP1MMP7
SCHEMBL7332133 0.83 ADAMTS4 (0.55) ELANEADAMTS4MMP13MMP1MMP7
SCHEMBL7423261 0.78 ELANE (0.47) ELANEMMP8MMP12MMP13MMP1
SCHEMBL7421516 0.78 MBTPS1 (0.43) ADAMTS4MMP13MMP1MMP7SMN1; SMN2
SCHEMBL7305790 0.72 CA2 (0.55) ADAMTS4SMN1; SMN2MEN1ALDH1A1KMT2A
SCHEMBL6446955 0.71 NPC1 (0.58) SMN1; SMN2ALDH1A1KMT2ARAB9ACYP1A2
SCHEMBL6446960 0.71 NPC1 (0.58) SMN1; SMN2ALDH1A1KMT2ARAB9ACYP1A2
SCHEMBL7333019 0.71 CA2 (0.64) ELANEHTTATMSMN1; SMN2MEN1
SCHEMBL7332837 0.71 CA2 (0.64) ELANEHTTATMSMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5256677-A Enzyme inhibitor for treating acquired immune deficiency syndrome ABBOTT LABORATORIES (US) 1993-10-26 US disclosed
WO-1992017176-A1 RETROVIRAL PROTEASE INHIBITING COMPOUNDS ABBOTT LABORATORIES (US) 1992-10-15 WO disclosed
US-5151438-A Enzyme inhibitors for treatment of aids ABBOTT LABORATORIES (US) 1992-09-29 US disclosed